Clin2
NCT07143279Possibly a fitRecruiting

Testosterone for quality of life in men with advanced cancer

HypotestosteronismPalliative Care

Part of Hormones & metabolism clinical trials.

This trial tests if testosterone supplements can improve quality of life for men with low testosterone who are no longer receiving active cancer treatment. It aims to help with symptoms like fatigue and low mood.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are a man with low testosterone (below 231 ng/dl).
  • You are receiving best supportive care and have no further cancer treatment options.
  • You are at least 18 years old.
  • You are able to understand and sign a consent form.
  • You do not have untreated prostate cancer.
  • You are not allergic to the study drug, peanuts, or soya.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04833426Recruiting· Phase 3
Testosterone levels around prostate surgery and recovery outcomes

This trial studies whether testosterone levels before and around radical prostate surgery affect cancer control and sexual/physical recovery. It may help doctors understand who benefits from testosterone replacement and who should not.

Amsterdam
NCT04049331Recruiting· Phase 2
Testosterone therapy for cancer survivors with fatigue

This trial tests whether testosterone replacement can help male cancer survivors who have ongoing fatigue and low testosterone levels. It is for men who have completed chemotherapy or radiation and are cancer-free for at least a year.

Boston, Massachusetts
NCT07278362Not yet recruiting· Phase 4
Testosterone therapy for low testosterone with low-risk prostate cancer

This study tests whether testosterone replacement therapy can safely improve low testosterone symptoms in men with low-risk prostate cancer who are under active surveillance. It aims to see if treatment can help without worsening the cancer.

Miami, Florida
NCT06733350Recruiting· Phase 4
Testosterone therapy for low testosterone in men with low-risk prostate cancer

This study tests whether testosterone replacement therapy can safely improve low testosterone levels in men with low-risk prostate cancer who are not getting immediate treatment. It aims to help men feel better without worsening their cancer.

Buffalo, New York
NCT07768917Not yet recruiting
Exercise training for men starting hormone therapy for prostate cancer

This study tests whether a supervised exercise program can help manage side effects like fatigue and muscle loss when starting hormone therapy for prostate cancer. Participation may improve your quality of life during treatment.

Boston, Massachusetts
NCT07535905Not yet recruiting· Phase 2
Tamoxifen to help testosterone return after hormone therapy

This study tests whether tamoxifen, a pill that blocks estrogen, can help your testosterone levels recover faster after you finish hormone therapy for prostate cancer. It may reduce side effects like fatigue and low sex drive.

Toronto, Ontario

Hear when a new Palliative Care trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.